期刊
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
卷 35, 期 3, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.berh.2021.101666
关键词
Systemic sclerosis; Scleroderma; Gastrointestinal; Management
类别
资金
- NIH/NIAMS [K23 AR071473]
- Scleroderma Research Foundation
- Jerome L. Greene Foundation
Systemic sclerosis often affects the gastrointestinal tract, leading to impaired function and significant morbidity. This article consolidates current guidelines and proposes a symptom-based framework for diagnosis and management, while also identifying areas in need of further research.
The gastrointestinal (GI) tract is the most commonly affected internal organ system in systemic sclerosis (SSc). SSc may lead to impaired function in any region of the GI tract, from the esophagus to the anorectum, which causes significant morbidity as well as mortality in patient subsets. Given the low prevalence of SSc in the community, many rheumatologists may not have a systematic framework for diagnosing or treating the GI complaints in this disease. These practice recommendations aim to summarize and consolidate the current guidelines from the fields of gastroenterology and rheumatology and establish a symptom-based framework for diagnosis and management based on available evidence in the literature. Subject areas that are in need of additional research are also identified. (C) 2021 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据